BASF SE BASFY announced that it is evaluating a potential investment in India to establish a methylene diphenyl diisocyanate (MDI) production complex in Dahej, Gujarat, to address the growing regional customer demand. The company is in the advanced stages of a feasibility study and has secured an industrial land parcel through its Indian subsidiary, BASF India Polyurethanes Private Limited.
MDI is a key raw material used in polyurethane products for building insulation, refrigeration, automotive components, furniture and consumer goods. The investment plan is aligned with BASF’s ‘Winning Ways’ strategy and local-for-local approach, which focuses on strengthening core businesses and expanding its manufacturing footprint.
The potential facility would ensure reliable supply of locally produced MDI to customers across India and neighboring markets. The investment decision will depend on the feasibility study’s outcome and remain subject to necessary approvals.
The proposed project would complement BASF’s global MDI production network, which includes facilities in the United States, Belgium, China and South Korea. Meanwhile, the company’s $1 billion MDI expansion project in Geismar, LA, is entering its final phase.
BASF’s existing operations in Dahej, including an MDI splitter and polyurethane production facilities, provide a strong foundation for the potential investment. India’s expanding urbanization, infrastructure development and manufacturing activity are expected to support demand for high-performance materials, creating growth opportunities for BASF India.
BASFY’s shares have gained 17.2% in the past year compared with the industry’s 1.7% decline in the same period.
Image Source: Zacks Investment Research
BASFY’s Zacks Rank & Key Picks
BASFY currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Reliance, Inc. RS, Kronos Worldwide, Inc. KRO and Avient Corporation AVNT.
While RS currently sports a Zacks Rank #1 (Strong Buy), KRO and AVNT carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $22.23 per share, indicating a 55.89% year-over-year increase. RS’shares have gained 35.9% over the past year.
The Zacks Consensus Estimate for KRO’s 2026 earnings is pegged at 35 cents per share, indicating a rise of 136.46% year over year. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters while missing it in the rest, with an average surprise of 33.99%.
The Zacks Consensus Estimate for AVNT’s current-year earnings is pinned at $3.2 per share, indicating a 13.48% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%. AVNT’sshares have gained 17.6% over the past year.
Radical New Technology Could Hand Investors Huge Gains
Quantum Computing is the next technological revolution, and it could be even more advanced than AI.
While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.
Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power .
Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.
See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BASF SE (BASFY): Free Stock Analysis Report
Reliance, Inc. (RS): Free Stock Analysis Report
Kronos Worldwide Inc (KRO): Free Stock Analysis Report
Avient Corporation (AVNT): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).